SCHEMBL21392964

SCHEMBL21392964

O=C(CCl)N(Cc1ccccc1)c1ccc2c(c1)OCO2

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.62
RAB9A P51151 5/20 0.62
PAX8 Q06710 3/20 0.62
MEN1 O00255 3/20 0.62
KMT2A Q03164 3/20 0.62
GPX4 P36969 1/20 0.62
ALDH1A1 P00352 4/20 0.61
HTT P42858 3/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
GLA P06280 1/20 0.61
TRPM8 Q7Z2W7 5/20 0.58
JAK2 O60674 2/20 0.57
LMNA P02545 1/20 0.57
MAPT P10636 1/20 0.57
HPGD P15428 1/20 0.52
FNIP1 Q8TF40 1/20 0.52
FEM1B Q9UK73 1/20 0.52
RNF4 P78317 1/20 0.51
PTPN1 P18031 1/20 0.49
TSHR P16473 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20456266 0.92 ALDH1A1 (0.66) NPC1RAB9APAX8MEN1KMT2A
SCHEMBL21401721 0.85 KMT2A (0.66) NPC1RAB9APAX8MEN1KMT2A
SCHEMBL21392822 0.85 KMT2A (0.66) NPC1RAB9APAX8MEN1KMT2A
SCHEMBL21392985 0.84 MEN1 (0.64) NPC1RAB9APAX8MEN1KMT2A
SCHEMBL21393074 0.83 NPC1 (0.62) NPC1RAB9APAX8MEN1KMT2A
SCHEMBL21401863 0.82 KMT2A (0.62) NPC1RAB9APAX8MEN1KMT2A
SCHEMBL21393072 0.81 NPC1 (0.57) NPC1RAB9APAX8MEN1KMT2A
SCHEMBL31104078 0.81 FNIP1 (0.58) NPC1RAB9APAX8MEN1KMT2A
SCHEMBL23818424 0.81 KMT2A (0.58) NPC1RAB9APAX8MEN1KMT2A
SCHEMBL21392987 0.81 KMT2A (0.61) NPC1RAB9APAX8MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11666661-B2 Methods and compounds for targeted autophagy THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-06-06 US disclosed
US-11666661-B2 Methods and compounds for targeted autophagy THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-06-06 US disclosed
US-20190290778-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY FRONTIER MEDICINES CORPORATION 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190290778-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY ATG7, BECN1, SQSTM1 NPC1 37/4885RAB9A 223/4885PAX8 3382/4885
US-11666661-B2 Methods and compounds for targeted autophagy ATG7, BECN1, SQSTM1 NPC1 37/4885RAB9A 223/4885PAX8 3382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.